For Industry
SCROLL DOWN
We connect industry partners with Canada’s leading pediatric rare disease experts, investigators, and research ready sites. Our network provides tailored support, from site and investigator identification to regulatory guidance and patient partner input, to streamline study start up, strengthen trial design, and accelerate progress towards new treatments.
Eligible projects must meet the following criteria:
We have over 180 experts in our expertise database and 16 Clinical Trial Navigators across Canada to assist with feasibility assessments and site identification for your research.
Our personalized and collaborative approach has proven highly effective by driving stronger engagement and higher response rates from investigators and sites for innovate research opportunities.
Interventional clinical trial
Intervention impacting a pediatric population (or, in the case of pregnancy, the fetus rather than the mother)
Includes conditions with an Orpha code on Orpha.Net or has a prevalence of less than 1 in 2,000
Exclusion of oncology clinical trials
For projects outside of this scope, please submit your project request to MICYRN
We provide expert guidance for Health Canada submissions to support your clinical trial. Our team helps industry partners navigate regulatory requirements in Canada, accelerating the path to study start up.
We connect industry partners with a national network of over 180 experts from our expertise database, as well as engaged patient partners. Through this collaboration, we help strengthen study design and enhance impact of clinical trials across Canada.